Home » Topics » Briefs » Other news to note

Other news to note
RSS

Genentech licenses rights to Afraxis compounds

Jan. 30, 2013

Bristol-Myers Squibb reviews progress of fourth quarter 2012

Jan. 30, 2013

Antitope forms protein deimmunization agreement

Jan. 28, 2013

Novartis presents highlights of fourth quarter 2012

Jan. 28, 2013

Biscayne Pharmaceuticals to advance GHRH drug research

Jan. 24, 2013

Infinity Pharmaceuticals details plans for 2013

Jan. 24, 2013

Onyx Pharmaceuticals achieves development goals

Jan. 24, 2013

Approvals and regulatory submissions mark Johnson & Johnson's fourth quarter 2012

Jan. 24, 2013

Progenics acquires Molecular Insight Pharmaceuticals

Jan. 23, 2013

Ablynx development priorities detailed at J.P. Morgan Healthcare Conference

Jan. 23, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...